Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Caribou Biosciences

Explore full profile

Biotechnology company focused on genome engineering and developing technology-based solutions for cells

Berkeley, United StatesFounded 2011Biotech & Life Sciences
Valuation $54M Market cap · Aug/2026
Revenue $26M Latest reported FY

At a glance

Founded
2011
Headquarters
Berkeley, United States
Listing
IPO 2021
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierColt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning Caribou Biosciences.

See all news

Investors

29 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Series B and later23 investors entered at this stage

  • F-Prime
  • Janus Henderson Investors
  • Tekla Capital Management
  • Farallon Capital Management
  • Avego Bioscience Capital
  • LifeSci Venture Partners
  • Avidity Partners
  • Monashee Investment Management
  • Pontifax AgTech
  • Ridgeback Capital
  • AbbVie
  • Mission Bay Capital
  • Adage Capital
  • Heritage Medical Systems
  • The Leukemia & Lymphoma Society
  • Point72 Ventures
  • Maverick Capital
  • Anterra Capital
  • University of California
  • Berkeley
  • PFM Health Sciences
  • Invus
  • Heritage Group

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 startups

Former Caribou Biosciences employees who went on to found companies, sorted by Dealroom signal score.

Intellia TherapeuticsEst. 2014
AMAndy MayUnited States
Signal score86
Laguna BioEst. 2022
Jonathan KotulaUnited States
Signal score84
Locus BiosciencesEst. 2015
Rodolphe Barrangou.United States
Signal score76
Vetmab BiosciencesEst. 2022
Richard ChinUnited States
Signal score70
Editas MedicineEst. 2013
Jennifer A. DoudnaUnited States
Signal score62
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
8.8K monthly visits
across markets
🇺🇸 United States80.7%
🇮🇳 India11.4%
🇯🇵 Japan8%
Top 3 markets shown

Patents

Estimated portfolio value
$98M

33 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Caribou Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Caribou Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles